J Mark Enyedy

Affiliations

  • Director at Charles River Laboratories International Inc. (CRL), 2025-06-04
  • Director at Biomarin Pharmaceutical Inc (BMRN), 2025-05-22
  • Chief Executive Officer at Immunogen Inc. (IMGN), 2024-02-12
  • Director at Logicbio Therapeutics Inc. (LOGC), 2022-11-18
  • at Akebia Therapeutics Inc. (AKBA), 2020-06-09
  • Director at Keryx Biopharmaceuticals Inc (KERX), 2018-12-13
  • Director at Fate Therapeutics Inc (FATE), 2017-05-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IMGN $1.83 25,000 $45,737.50 100,100 2016-11-08 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
IMGN $29.28 20,107 $588,732.96 584,397 2024-02-05 Filing
IMGN $16.96 992,397 $16,831,053.12 553,270 2023-08-04 Filing
IMGN $16.61 1,020,000 $16,942,200.00 441,449 2023-08-03 Filing
IMGN $18.15 8,636 $156,743.40 441,449 2023-08-02 Filing
IMGN $17.45 986,521 $17,214,791.45 450,085 2023-08-02 Filing